- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07464158
WRITE: Written Imaginal Thinking Exercise Study (WRITE)
April 27, 2026 updated by: Nora Barnes-Horowitz, University of Colorado, Boulder
Written Imaginal Thinking Exercise (WRITE) Study
The purpose of the study is to investigate and compare the effects of three different versions of a future imaginal writing exercise (worst-case scenario, neutral future scenario, best-case scenario) for individuals with elevated social anxiety symptoms.
Participants (N=270) will be recruited through the online platform, Prolific, and will be randomly assigned to one of three writing exercise conditions.
Participants will complete three study sessions across approximately three weeks.
Study session 1 (T1) will consist of baseline assessments and pre-writing ratings, a future imaginal writing exercise, and then post-writing ratings.
Study session 2 (T2) will occur approximately one week later and will consist of mid-study assessments and pre-writing ratings, a second, repeated future imaginal writing exercise, and then post-writing ratings.
Finally, study session 3 (T3) will occur approximately one week later (approximately two weeks after T1) and will consist of follow-up assessments and repeated post-writing ratings.
Study Overview
Status
Enrolling by invitation
Conditions
Study Type
Interventional
Enrollment (Estimated)
270
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Boulder, Colorado, United States, 80309
- University of Colorado Boulder
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- English fluency
- Previous high-quality Prolific submission experience
- Elevated social anxiety symptoms
Exclusion Criteria:
- Hospitalization for psychiatric reasons within the past year
- Previous suicide attempt or self-harm
- Previous treatment for severe head injury or past repeated serious head injury
- Current psychosis symptoms
- Elevated trauma symptoms
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Worst-Case Scenario
|
Written exposure exercise about an imagined future worst-case scenario.
|
|
Active Comparator: Neutral Future Scenario
|
Written exercise about an imagined neutral future scenario.
|
|
Experimental: Best-Case Scenario
|
Written exposure exercise about an imagined future best-case scenario.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Social Phobia Inventory (SPIN)
Time Frame: Baseline through study completion, an average of 3 weeks.
|
Social anxiety symptom severity, range: 0-68 total, higher scores indicate higher social anxiety symptom severity.
|
Baseline through study completion, an average of 3 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Health Questionnaire (PHQ-8)
Time Frame: Baseline through study completion, an average of 3 weeks.
|
Depression symptom severity, range: 0-24 total, higher scores indicate higher depression symptom severity.
|
Baseline through study completion, an average of 3 weeks.
|
|
Overall Anxiety Severity and Impairment Scale (OASIS)
Time Frame: Baseline through study completion, an average of 3 weeks.
|
General anxiety symptom severity, range: 0-20 total, higher scores indicate higher general anxiety symptom severity.
|
Baseline through study completion, an average of 3 weeks.
|
|
Social Approach Motivation
Time Frame: Baseline through study completion, an average of 3 weeks.
|
Self-reported rating of motivation for social approach over the next week.
Rating ranges from 0 (not motivated at all) to 100 (extremely motivated).
|
Baseline through study completion, an average of 3 weeks.
|
|
Positive and Negative Affect Schedule (PANAS-10)
Time Frame: Baseline through study completion, an average of 3 weeks.
|
Positive and negative affect, range: 5-25 each (total score), higher scores indicate higher positive and negative affect.
|
Baseline through study completion, an average of 3 weeks.
|
|
Cognitive Emotion Regulation Questionnaire (CERQ): Catastrophizing and Positive Reappraisal subscales
Time Frame: Baseline through study completion, an average of 3 weeks.
|
Use of catastrophizing and positive reappraisal cognitive emotion regulation strategies, range: 1-5 each (average score), higher score reflects higher degree of use of strategy.
|
Baseline through study completion, an average of 3 weeks.
|
|
Threat-related prediction ratings
Time Frame: Baseline through study completion, an average of 3 weeks.
|
Self-reported ratings of 1) likelihood of feared situation avoidance, 2) likelihood of feared outcome occurrence, 3) predicted intensity of feared outcome occurrence, 4) likelihood of best possible outcome occurrence, and 5) predicted intensity of best possible outcome occurrence.
All ratings range from 0 (0% likely/not bad at all/not good at all) to 100 (100% likely/as bad as I can possibly imagine/as good as I can possibly imagine).
|
Baseline through study completion, an average of 3 weeks.
|
|
State emotion ratings
Time Frame: Baseline through study completion, an average of 3 weeks.
|
Self-reported state ratings of 1) positive affect, and 2) anxiety.
All ratings range from 0 (not positive/anxious at all) to 100 (extremely positive/anxious).
|
Baseline through study completion, an average of 3 weeks.
|
|
Writing exercise experience ratings - writing qualities
Time Frame: After each writing exercise, an average of 2 weeks.
|
Self-reported ratings of vividness/detail and effort of the writing.
All ratings range from 0 (not at all) to 100 (extremely), higher scores reflect greater vividness/detail and effort.
|
After each writing exercise, an average of 2 weeks.
|
|
Writing exercise experience ratings - perceived learning
Time Frame: After each writing exercise, an average of 2 weeks.
|
Self-reported ratings of perceived learning and perspective shift from the writing exercises.
All ratings range from 0 (strongly disagree) to 4 (strongly agree).
Higher scores reflect greater perceived learning and perspective shift.
|
After each writing exercise, an average of 2 weeks.
|
|
Behavioral approach/avoidance
Time Frame: At the final study session, approximately 3 weeks after Baseline.
|
Single self-reported rating of willingness to engage in a feared situation.
Binary yes/no response, where yes indicates willingness to approach and no indicates avoidance.
|
At the final study session, approximately 3 weeks after Baseline.
|
|
Program feedback ratings - overall
Time Frame: At the final study session, approximately 3 weeks after Baseline.
|
Ratings assessing overall program feedback (range: 0-28, higher scores reflect more positive overall program feedback).
|
At the final study session, approximately 3 weeks after Baseline.
|
|
Program feedback ratings - perceived benefit
Time Frame: At the final study session, approximately 3 weeks after Baseline.
|
Rating assessing perceived benefit of the writing exercises (range: 0-4, higher scores reflect higher perceived benefit).
|
At the final study session, approximately 3 weeks after Baseline.
|
|
Program feedback ratings - likelihood of future use
Time Frame: At the final study session, approximately 3 weeks after Baseline.
|
Rating assessing likelihood of future use of writing exercises (range: 0-100, higher scores reflect higher likelihood of future use).
|
At the final study session, approximately 3 weeks after Baseline.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 21, 2026
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
March 1, 2027
Study Registration Dates
First Submitted
March 2, 2026
First Submitted That Met QC Criteria
March 5, 2026
First Posted (Actual)
March 11, 2026
Study Record Updates
Last Update Posted (Actual)
April 28, 2026
Last Update Submitted That Met QC Criteria
April 27, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 25-0771
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress
-
Massachusetts General HospitalCompletedStress | Emotional Stress | Psychological Stress | Social Stress | Life StressUnited States
-
Center for Advanced Facial Plastic SurgeryCompletedStress | Stress, Physiological | Stress Response | Stress (Psychology) | Healthy Adult Female Participants | Stress, Psychologic | Stress Perception | Stress Levels | Stress, Psychological CumulativeUnited States
-
Amsterdam UMC, location VUmcRigshospitalet, Denmark; Universitätsklinikum Hamburg-EppendorfNot yet recruitingStress | Stress and Burnout | Stress BiomarkersGermany, Denmark
-
University of California, Los AngelesUniversity of California, San Francisco; Stanford University; California Initiative...CompletedStress | Stress, Psychological | Stress, Emotional | Stress, Physiological | Stress ReactionUnited States
-
Amasya UniversityCompletedThe Effect of Online Stress Management Program on Nurses' Individual Workload Perception, and StressStress | Nursing | Stress ManagementTurkey (Türkiye)
-
Canterbury Christ Church UniversitySussex Partnership NHS Foundation TrustEnrolling by invitationOccupational Stress or Workplace StressUnited Kingdom
-
University of PadovaCompletedStress | Stress Disorder | Work Related StressItaly
-
University of Thi-QarCompletedPsychological Stress | Academic StressIraq
-
Dana-Farber Cancer InstituteCompletedStress | Post Traumatic Stress Disorder | Work Related StressUnited States
-
University of North Carolina, Chapel HillWashington University School of Medicine; United States Department of Defense; University of Florida and other collaboratorsRecruitingPost-traumatic Stress Disorder | Acute Stress Disorder | Acute Stress ReactionUnited States